^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Pituitary Gland Carcinoma

Related cancers:
1m
Plumbagin Induces Ferroptosis in Nonfunctioning Pituitary Adenomas via Nrf2/FTH1-Dependent Ferritinophagy. (PubMed, Drug Des Devel Ther)
Compared to temozolomide (TMZ), PLB more potently inhibited the viability of PDFS cells...The mechanism involves suppression of the Nrf2/FTH1 pathway, subsequent upregulation of NCOA4, and ferritinophagy-driven iron overload. These results identify PLB as a potential ferroptosis inducer and warrant further investigation into its therapeutic potential for NFPA.
Journal
|
NCOA4 (Nuclear Receptor Coactivator 4)
|
temozolomide
1m
Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas. (PubMed, Endocr Metab Immune Disord Drug Targets)
These findings may contribute to understanding the genetic landscape of acromegaly, and the gene identified may be of interest for further research on gene regulation of invasiveness and proliferation in somatotropinomas.
Journal
|
KCNJ12 (Potassium Inwardly Rectifying Channel Subfamily J Member 12)
1m
Hyperlactataemia in lymphoma-associated haemophagocytic lymphohistiocytosis: Linked to monocytic glycolysis and adverse prognosis. (PubMed, Br J Haematol)
Our findings indicate that LAHS is characterized by a pronounced Warburg-like metabolic state, primarily involving glycolytic monocytes. Hyperlactataemia is associated with adverse outcomes and may guide the development of novel therapeutic strategies targeting immunometabolic pathways.
Journal
|
PTTG1 (PTTG1 Regulator Of Sister Chromatid Separation, Securin)
1m
GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegaly. (PubMed, Pituitary)
These findings support that GH responsiveness to CRH identifies a biologically distinct subset of somatotroph adenomas characterized by corticotroph-like features, larger tumor size, and reduced GH secretory capacity. GH responsiveness to CRH may serve as a noninvasive indicator of intrinsic tumor biology and behavior.
Retrospective data • Journal
|
SSTR (Somatostatin Receptor) • IGF1 (Insulin-like growth factor 1)
1m
Pituitary metastasis as an endocrine-neuro-ophthalmologic emergency: clinical red flags and outcomes from a contemporary tertiary-center series. (PubMed, Pituitary)
Pituitary metastasis frequently presents with combined endocrine dysfunction and neuro-ophthalmologic compromise, occasionally as an acute sellar emergency. In oncologic patients with sellar lesions, the combination of AVP-D, visual deterioration, and non-prolactinoma-range hyperprolactinemia should raise suspicion for pituitary metastasis and prompt urgent endocrine and local evaluation.
Retrospective data • Journal
|
PRL (Prolactin)
1m
Postoperative changes in circulating brain injury biomarkers in relation to long-term fatigue and cognitive outcomes after surgery for nonfunctioning pituitary adenomas. (PubMed, Pituitary)
Endoscopic transsphenoidal surgery for NFPAs is associated with transient increases in circulating brain injury biomarkers, particularly in patients with hypothalamic compression. Our findings revealed that these elevations were not related to long-term fatigue or cognitive decline, suggesting that they may reflect short-term surgical effects without sustained functional consequences.
Journal
|
GFAP (Glial Fibrillary Acidic Protein) • NEFL (Neurofilament Light Chain)
1m
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery (clinicaltrials.gov)
P=N/A, N=20, Recruiting, West China Hospital | Not yet recruiting --> Recruiting
Enrollment open
1m
Dominant T cell receptor clonotypes in adrenocorticotropic hormone-secreting pituitary carcinoma are the highest-frequency clones among CD4+ and CD8+ cells in peripheral blood during effective anti-PD-1 therapy. (PubMed, Front Immunol)
Despite control of the primary and hepatic lesions, ovarian metastasis developed, which was associated with reduced CD4+ TILs. The presence of CD4+ and CD8+ TILs may underlie the immunological foundation for PD-1 blockade efficacy in pituitary carcinoma, supported by the detection of tumor-resident TCR clonotypes in peripheral blood during a positive therapeutic response.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
1m
Identification of Differentially Expressed Genes in Non-functioning Pituitary Adenoma by Transcriptome Analysis. (PubMed, In Vivo)
CCND1, POU5F1, SOX2, HNF1A, BRCA1, and FOXA1 were identified as key molecules that may serve as potential biomarkers for diagnosis and targeted therapy of NFPA.
Journal • BRCA Biomarker
|
BRCA1 (Breast cancer 1, early onset) • CCND1 (Cyclin D1) • FOXA1 (Forkhead Box A1) • SOX2 • POU5F1 (POU Class 5 Homeobox 1) • PRLR (Prolactin Receptor 2) • HNF1A (HNF1 Homeobox A)
1m
Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years. (PubMed, J Clin Endocrinol Metab)
Once-daily oral paltusotine treatment was well tolerated and resulted in long-term disease control, including biochemical, symptom, and pituitary tumor stability, for up to 4 years.
Journal
|
SSTR (Somatostatin Receptor) • IGF1 (Insulin-like growth factor 1)
|
Signifor (pasireotide) • Palsonify (paltusotine)
1m
Pituitary adenoma-associated with Schöpf-Schulz-Passarge syndrome. (PubMed, BMJ Case Rep)
Raised serum prolactin has not been previously associated with Schöpf-Schulz-Passarge syndrome. The significance of raised serum prolactin in the context of multiple eyelid hidrocystomas is discussed.
Journal
|
PRL (Prolactin)
1m
Hydrogel-based lineage-specific gene therapy prevents recurrence of corticotroph tumors. (PubMed, Mol Ther Oncol)
In vivo, the virus suppressed tumor growth and lessened systemic tumor effects; when delivered via the hydrogel into surgical cavities, it completely eliminated residual tumors without detectable toxicity in major organs. This targeted, localized strategy, thus has translational potential as an adjuvant therapy for reducing the recurrence of Cushing's disease.
Journal
|
BBC3 (BCL2 Binding Component 3)